Cargando…

Congenital muscular dystrophy with inflammation: Diagnostic considerations

BACKGROUND AND PURPOSE: Muscle biopsy features of congenital muscular dystrophies (CMD) vary from usual dystrophic picture to normal or nonspecific myopathic picture or prominent fibrosis or striking inflammatory infiltrate, which may lead to diagnostic errors. A series of patients of CMD with signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Konkay, Kaumudi, Kannan, Meena Angamuthu, Lingappa, Lokesh, Uppin, Megha S., Challa, Sundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980959/
https://www.ncbi.nlm.nih.gov/pubmed/27570388
http://dx.doi.org/10.4103/0972-2327.186814
_version_ 1782447547141324800
author Konkay, Kaumudi
Kannan, Meena Angamuthu
Lingappa, Lokesh
Uppin, Megha S.
Challa, Sundaram
author_facet Konkay, Kaumudi
Kannan, Meena Angamuthu
Lingappa, Lokesh
Uppin, Megha S.
Challa, Sundaram
author_sort Konkay, Kaumudi
collection PubMed
description BACKGROUND AND PURPOSE: Muscle biopsy features of congenital muscular dystrophies (CMD) vary from usual dystrophic picture to normal or nonspecific myopathic picture or prominent fibrosis or striking inflammatory infiltrate, which may lead to diagnostic errors. A series of patients of CMD with significant inflammatory infiltrates on muscle biopsy were correlated with laminin α2 deficiency on immunohistochemistry (IHC). MATERIAL AND METHODS: Cryostat sections of muscle biopsies from the patients diagnosed as CMD on clinical and muscle biopsy features from 1996 to 2014 were reviewed with hematoxylin and eosin(H&E), enzyme and immunohistochemistry (IHC) with laminin α2. Muscle biopsies with inflammatory infiltrate were correlated with laminin α2 deficiency. RESULTS: There were 65 patients of CMD, with inflammation on muscle biopsy in 16. IHC with laminin α2 was available in nine patients, of which six showed complete absence along sarcolemma (five presented with floppy infant syndrome and one with delayed motor milestones) and three showed discontinuous, and less intense staining. CONCLUSIONS: CMD show variable degrees of inflammation on muscle biopsy. A diagnosis of laminin α2 deficient CMD should be considered in patients of muscular dystrophy with inflammation, in children with hypotonia/delayed motor milestones.
format Online
Article
Text
id pubmed-4980959
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49809592016-08-26 Congenital muscular dystrophy with inflammation: Diagnostic considerations Konkay, Kaumudi Kannan, Meena Angamuthu Lingappa, Lokesh Uppin, Megha S. Challa, Sundaram Ann Indian Acad Neurol Original Article BACKGROUND AND PURPOSE: Muscle biopsy features of congenital muscular dystrophies (CMD) vary from usual dystrophic picture to normal or nonspecific myopathic picture or prominent fibrosis or striking inflammatory infiltrate, which may lead to diagnostic errors. A series of patients of CMD with significant inflammatory infiltrates on muscle biopsy were correlated with laminin α2 deficiency on immunohistochemistry (IHC). MATERIAL AND METHODS: Cryostat sections of muscle biopsies from the patients diagnosed as CMD on clinical and muscle biopsy features from 1996 to 2014 were reviewed with hematoxylin and eosin(H&E), enzyme and immunohistochemistry (IHC) with laminin α2. Muscle biopsies with inflammatory infiltrate were correlated with laminin α2 deficiency. RESULTS: There were 65 patients of CMD, with inflammation on muscle biopsy in 16. IHC with laminin α2 was available in nine patients, of which six showed complete absence along sarcolemma (five presented with floppy infant syndrome and one with delayed motor milestones) and three showed discontinuous, and less intense staining. CONCLUSIONS: CMD show variable degrees of inflammation on muscle biopsy. A diagnosis of laminin α2 deficient CMD should be considered in patients of muscular dystrophy with inflammation, in children with hypotonia/delayed motor milestones. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4980959/ /pubmed/27570388 http://dx.doi.org/10.4103/0972-2327.186814 Text en Copyright: © Annals of Indian Academy of Neurology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Konkay, Kaumudi
Kannan, Meena Angamuthu
Lingappa, Lokesh
Uppin, Megha S.
Challa, Sundaram
Congenital muscular dystrophy with inflammation: Diagnostic considerations
title Congenital muscular dystrophy with inflammation: Diagnostic considerations
title_full Congenital muscular dystrophy with inflammation: Diagnostic considerations
title_fullStr Congenital muscular dystrophy with inflammation: Diagnostic considerations
title_full_unstemmed Congenital muscular dystrophy with inflammation: Diagnostic considerations
title_short Congenital muscular dystrophy with inflammation: Diagnostic considerations
title_sort congenital muscular dystrophy with inflammation: diagnostic considerations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980959/
https://www.ncbi.nlm.nih.gov/pubmed/27570388
http://dx.doi.org/10.4103/0972-2327.186814
work_keys_str_mv AT konkaykaumudi congenitalmusculardystrophywithinflammationdiagnosticconsiderations
AT kannanmeenaangamuthu congenitalmusculardystrophywithinflammationdiagnosticconsiderations
AT lingappalokesh congenitalmusculardystrophywithinflammationdiagnosticconsiderations
AT uppinmeghas congenitalmusculardystrophywithinflammationdiagnosticconsiderations
AT challasundaram congenitalmusculardystrophywithinflammationdiagnosticconsiderations